Cognitive Remediation Program for Hospitalized in the Long Term Patients With Deficit Schizophrenia (IPT+)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03407950|
Recruitment Status : Not yet recruiting
First Posted : January 23, 2018
Last Update Posted : January 23, 2018
|Condition or disease||Intervention/treatment||Phase|
|Schizophrenia||Behavioral: IPT+ Behavioral: Treatment as usual||Not Applicable|
Schizophrenia is a chronic disease with deficit in social interaction and lost of autonomy in daily life. Negative symptoms as blunted affect, avolition, social deficit and anhedonia and cognition were prognosis and functioning key's factors. Psychotropic medications have shown only poor effect to improve negative symptoms and cognition as attention, memory and cognitive flexibility. So, cognitive remediation programs were developped to focus cognitive disorders. The IPT (Integrated Psychological Treatment) is one of the most complete program with modules on cognitive and social abilities. The aim of this study is to evaluate the efficacy of IPT+ program to improve autonomy capacities of long stay inpatients suffering from schizophrenia 6 at the end of the program The secondary objectives are to evaluate autonomy 6 months after the program, to evaluate the efficacy of the program on negative symptoms, quality of life, cognitive functions, social cognition and duration of hospitalisation.
This study propose a randomised controlled study with 2 arms, with blind evaluation to compare the IPT+ versus treatment as usual (TAU). The follow up will be 6 month for the With IPT+ this study will improve autonomy capacities for patients suffering from deficit schizophrenia and allowed patients to go out hospital earlier than before.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||208 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Cognitive Remediation Program for Hospitalized in the Long Term Patients With Deficit Schizophrenia : Impact on the Capacities of Autonomy|
|Estimated Study Start Date :||January 2018|
|Estimated Primary Completion Date :||December 2020|
|Estimated Study Completion Date :||September 2021|
2 sessions of IPT+ by week during 6 months
Integrated Psychological Treatment and cognitive remediation and relaxation and Mindfulness : IPT+. A blind evaluation will be realized thanks to questionnaires of the current practice to compare the IPT+ versus treatment as usual (TAU).
group without specific therapy (Treatment as usual) but same number and duration of each sessions than IPT+
Behavioral: Treatment as usual
no specific therapy but same number and duration of each sessions than IPT+. A blind evaluation will be realized thanks to questionnaires of the current practice to compare the IPT+ versus treatment as usual (TAU).
- Social autonomy [ Time Frame: 6 months ]Evaluated by Social autonomy Scale (EAS). It's a scale composing by 17 highly-rated items from 0 to 6 (total score varying 0 in 102, a low score indicating a better social autonomy).
- Clinical symptomatology [ Time Frame: 6 and 12 months ]Evaluated by the Assessment of Negative Symptoms (SANS). It's a scale composing by 25 items, highly-rated from 0 to 5.
- Clinical symptomatology [ Time Frame: 6 and 12 months ]Evaluated by the Lille Apathy Rating Scale (LARS). It's a scale composing by 33 questions distributed in 9 columns. A global score is calculated varying of "36-22" (No apathetic person), "21-17" (trend to the apathy), "-16 in -10" (Moderate apathy) and of "-9 has + 36" (Severe apathy).
- Clinical symptomatology [ Time Frame: 6 and 12 months ]Evaluated by the Social Anhedonia Scale (SAS). It's a scale composing by 40 items quoted by the subject in "truth" or "false".
- Clinical cognition [ Time Frame: 6 and 12 months ]Evaluated by scale D2 test
- Clinical cognition [ Time Frame: 6 and 12 months ]Evaluated by scale Trail Making Test (TMT)
- Clinical cognition [ Time Frame: 6 and 12 months ]Evaluated by scale California Verbal Learning Test (CVLT)
- Clinical cognition [ Time Frame: 6 and 12 months ]Evaluated by scale WAIS III. The total score varies between 0 and 21
- Clinical cognition [ Time Frame: 6 and 12 months ]Evaluated by scale ER-40. It's an computer-based testing translates into French and which lasts 6 minutes. It consists with 40 photos of faces expressing 4 basic feelings (enjoyment, sadness, anger and fear) or neutrals. In every thrown image, 5 choices of feelings are possible.
- Clinical cognition [ Time Frame: 6 and 12 months ]Evaluated by Social cognition. A score of global social support will be estimated, between 0 (no knowledge, no possibility of emotional or financial support by other people) and 5 (patient having the possibility of living or living at a close person, anybody () gets fresh ideas worrying about the patient and about his coverage(care) and suggesting accompanying him(it) in the diverse administrative procedures or with care, very supported and varied emotional circle of acquaintances, possible financial support by the close friends(relations) and the guarantor(respondent) entirely for the necessities of the patient).
- Clinical cognition [ Time Frame: 6 and 12 months ]Evaluated by scale to assess Unawareness of Mental Disorder (SUMD). The answers are quoted(esteemed) from 1 to 5. The highest scores indicate the highest levels of non-consciousness of the disorder.
- Clinical functioning [ Time Frame: 6 and 12 months ]Evaluated by scales Quality of life (S-QoL-18)
- Clinical functioning [ Time Frame: 6 and 12 months ]Evaluated by scale Warwick-Edinburgh Mental Well-Being Scale (WEMWBS). Items are quoted of 1 (never) in 5 (all the time) giving a total score between 14 and 70.
- Clinical functioning [ Time Frame: 6 and 12 months ]Evaluated by scale Emotional Reactivity Scale (ERS). The 13 items are quoted of 0 (never) in 4 (always).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03407950
|Contact: Delphine CAPDEVIELLE, PU-PH||467339702 ext +email@example.com|
|Contact: Aurore LARUE, PHfirstname.lastname@example.org|
|Delphine CAPDEVIELLE||Not yet recruiting|
|Montpellier, France, 34295|
|Contact: Delphine CAPDEVIELLE, PU-PH email@example.com|
|Principal Investigator:||Delphine CAPDEVIELLE, PU-PH||University Hospital, Montpellier|